RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Essex Bio-Technology - Stock

Essex Bio-Technology P/S 2024

Essex Bio-Technology P/S

0.68

Ticker

1061.HK

ISIN

KYG312371035

WKN

693609

As of Jul 6, 2024, Essex Bio-Technology's P/S ratio stood at 0.68, a -46.46% change from the 1.27 P/S ratio recorded in the previous year.

The Essex Bio-Technology P/S history

Essex Bio-Technology Aktienanalyse

What does Essex Bio-Technology do?

Essex Bio-Technology Ltd is a biotechnology company that was founded in Essex, England in 1999. The company specializes in the research and development of innovative products in the healthcare sector, with a focus on the development of vaccines for globally prevalent diseases. Over the years, Essex Bio-Technology Ltd has evolved into a global company operating in Europe, Asia, Africa, and North America. It has offices in the UK, Canada, and China. The company is dedicated to improving the health and well-being of people worldwide, utilizing cutting-edge technology and scientific innovations. Its business model is based on the research, development, and marketing of biotechnology products for the pharmaceutical industry. One of the key areas of focus for Essex Bio-Technology Ltd is the discovery and development of vaccines. The company has made significant progress in particular in the development of vaccines for influenza and tuberculosis. It has also collaborated with other companies in the development of a vaccine for COVID-19. In addition to vaccines, Essex Bio-Technology Ltd has also developed products for medical diagnostics and cancer immunotherapy. These products are used in medical practice and have proven to be extremely successful. Overall, Essex Bio-Technology Ltd has developed an impressive range of products that cover important areas of healthcare. The products are of the highest quality and meet the highest standards in the biotechnology industry. In recent years, the company has established a strong partnership with the pharmaceutical industry. It has conducted collaborative research projects with some of the largest companies in the field to develop new biotechnology products. It has also played a central role in collaboration with governments and non-profit organizations worldwide to ensure that critical medical needs are met. Essex Bio-Technology Ltd stands for the highest quality standards and a commitment to improving healthcare. The company is a leader in biotechnological research and development and has made a name for itself in the pharmaceutical industry. It is a company to be proud of and one that is at the forefront of the journey towards better healthcare for all worldwide. Essex Bio-Technology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Essex Bio-Technology's P/S Ratio

Essex Bio-Technology's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Essex Bio-Technology's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Essex Bio-Technology's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Essex Bio-Technology’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Essex Bio-Technology stock

What is the price-to-earnings ratio of Essex Bio-Technology?

The price-earnings ratio of Essex Bio-Technology is currently 0.68.

How has the price-earnings ratio of Essex Bio-Technology changed compared to last year?

The price-to-earnings ratio of Essex Bio-Technology has increased by -46.46% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Essex Bio-Technology high compared to other companies?

Yes, the price-to-earnings ratio of Essex Bio-Technology is high compared to other companies.

How does an increase in the price-earnings ratio of Essex Bio-Technology affect the company?

An increase in the price-earnings ratio of Essex Bio-Technology would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Essex Bio-Technology affect the company?

A decrease in the price-earnings ratio of Essex Bio-Technology would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Essex Bio-Technology?

Some factors that influence the price-earnings ratio of Essex Bio-Technology are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Essex Bio-Technology pay?

Over the past 12 months, Essex Bio-Technology paid a dividend of 0.07 HKD . This corresponds to a dividend yield of about 2.99 %. For the coming 12 months, Essex Bio-Technology is expected to pay a dividend of 0.08 HKD.

What is the dividend yield of Essex Bio-Technology?

The current dividend yield of Essex Bio-Technology is 2.99 %.

When does Essex Bio-Technology pay dividends?

Essex Bio-Technology pays a quarterly dividend. This is distributed in the months of October, July, September, June.

How secure is the dividend of Essex Bio-Technology?

Essex Bio-Technology paid dividends every year for the past 0 years.

What is the dividend of Essex Bio-Technology?

For the upcoming 12 months, dividends amounting to 0.08 HKD are expected. This corresponds to a dividend yield of 3.3 %.

In which sector is Essex Bio-Technology located?

Essex Bio-Technology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Essex Bio-Technology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Essex Bio-Technology from 6/17/2024 amounting to 0.045 HKD, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Essex Bio-Technology pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Essex Bio-Technology in the year 2023?

In the year 2023, Essex Bio-Technology distributed 0.095 HKD as dividends.

In which currency does Essex Bio-Technology pay out the dividend?

The dividends of Essex Bio-Technology are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Essex Bio-Technology

Our stock analysis for Essex Bio-Technology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Essex Bio-Technology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.